Evidence map›Paper›PMID 40954216›Full record

ArticleLeukemia2025

Molecular profiling and risk stratification in solitary bone plasmacytoma.

Barbara Burroni, Stéphanie Harel, Raphaele Seror, Sophia Ascione, Youlia Kirova, Diane Damotte, Rakiba Belkhir, Thierry Lazure, Véronique Meignin, Justine Decroocq and 18 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Barbara BurroniDepartment of Pathology, GHU Paris Centre - Cochin-, AP-HP, Paris, France.
Stéphanie Harel *Department of Immuno Hematology, GHU Paris-Nord - Saint-Louis -AP-HP, Paris, France.ORCID http://orcid.org/0000-0002-9469-8336
Raphaele Seror *Department of Rheumatology, GHU Paris Saclay - Kremlin Bicêtre, AP-HP, Paris, France.ORCID http://orcid.org/0000-0002-5523-1856
Sophia AscioneDepartment of Rheumatology, GHU Paris Saclay - Kremlin Bicêtre, AP-HP, Paris, France.
Youlia KirovaDepartment of Radiation Oncology, Institut Curie, Paris, France.
Diane DamotteDepartment of Pathology, GHU Paris Centre - Cochin-, AP-HP, Paris, France.ORCID http://orcid.org/0000-0001-5355-3045
Rakiba BelkhirDepartment of Rheumatology, GHU Paris Saclay - Kremlin Bicêtre, AP-HP, Paris, France.
Thierry LazureDepartment of Pathology, GHU Paris Saclay, AP-HP, Paris, France.
Véronique MeigninDepartment of Pathology, GHU Paris-Nord - Saint-Louis, AP-HP, Paris, France.
Justine DecroocqDepartment of Hematology, GHU Paris Centre - Cochin-, AP-HP, Paris, France.
Virginie AudardDepartment of Pathology, GHU Paris Centre - Cochin-, AP-HP, Paris, France.
Rudy BirsenDepartment of Hematology, GHU Paris Centre - Cochin-, AP-HP, Paris, France.
Lise WillemsDepartment of Hematology, GHU Paris Centre - Cochin-, AP-HP, Paris, France.
Frédérique LarousserieDepartment of Pathology, GHU Paris Centre - Cochin-, AP-HP, Paris, France.
Patricia FranchiDepartment of Hematology, GHU Paris Centre - Cochin-, AP-HP, Paris, France.
Yoan VelutCentre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité, Team Inflammation, Complement and Cancer, Paris, France.ORCID http://orcid.org/0000-0003-1303-3146
Nicolas ChapuisUniversité Paris centre, Paris, France.ORCID http://orcid.org/0000-0003-0601-3948
Laure DerrierUnité de Génomique du Myélome, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.
Salomon ManierDepartment of Hematology, Lille University Hospital, University of Lille, Canther INSERM UMR-S1277 and CNRS UMR9020, Lille, France.
Bénédicte Deau-FischerDepartment of Hematology, GHU Paris Centre - Cochin-, AP-HP, Paris, France.
Julien HenryDepartment of Rheumatology, GHU Paris Saclay - Kremlin Bicêtre, AP-HP, Paris, France.
Luka PavageauUnité de Génomique du Myélome, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.
Alexis TalbotDepartment of Immuno Hematology, GHU Paris-Nord - Saint-Louis -AP-HP, Paris, France.ORCID http://orcid.org/0000-0001-6734-413X
Bruno RoyerDepartment of Immuno Hematology, GHU Paris-Nord - Saint-Louis -AP-HP, Paris, France.
Didier BouscaryDepartment of Hematology, GHU Paris Centre - Cochin-, AP-HP, Paris, France.
Bertrand ArnulfDepartment of Immuno Hematology, GHU Paris-Nord - Saint-Louis -AP-HP, Paris, France.
Jill CorreUnité de Génomique du Myélome, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.ORCID http://orcid.org/0000-0003-1580-6106
Marguerite VignonDepartment of Hematology, GHU Paris Centre - Cochin-, AP-HP, Paris, France. marguerite.vignon@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40954216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.